Cellis®

Collagen matrix
for soft tissue repair

Performing Abdominal Wall Repair is a challenge for even the highest experienced surgeons since multiples variables may affect the expected results of the surgery. Therefore the careful selection of the proper matrix and optimal surgical practices are really important to optimize the successfull outcome of the procedure.

CELLIS^® is one of the latest generation of biological implant combining drastic selection of tissues, exclusive manufacturing process preserving the natural structure of the dermis, no preservative and a moderate price.

Exclusive manufacturing process

CELLIS^® is manufactured with an exclusif process, based on our high experienced tissue acellularization. It has been developed with the aim of preserving the essential qualities of the best porcine dermis.

Naturally cross-linked: the purification process of MECCELLIS BIOTECH enables to preserve the natural structure of the dermis and thus its natural crosslinking. This exclusive process avoids the addition of chemical crosslinking agents.
Preservative-free: The CELLIS^® matrix uses the freeze dry technology which allows long-term preservation in a double sterile packaging without preservatives.

Download PDF documentation

Clinical cases

Cellis - Case n°1Abdominal compartment syndrome.
Cellis - Case n°2Granulation tissue formation following negative pressure therapy.

References

Sizes	References	Thicknesses
5 X 5 cm	C55E	1,4 mm
8 X 8 cm	C88E	0,9 mm
10 X 10 cm	CS1010F	0,9 mm
8 X 8 cm	CH88E	1,4 mm
10 X 10 cm	CS1010E	1,4 mm
10 X 15 cm	C1015E	1,4 mm
15 X 20 cm	C1520E	1,4 mm

Sizes	References	Thicknesses
18 X 25 cm	C1825E	1,4 mm
20 X 30 cm	C2030E	1,4 mm
30 X 30 cm	C3030E	1,4 mm
30 X 40 cm	C3040E	1,4 mm

	Sizes	References	Thicknesses
	6 X 18 X 3 cm	CR618EP	1,4 mm

Videos

CELLIS^®

Hiatus hernia treatment

CELLIS^®

Rectal prolapse treatment

CELLIS^®

Stoma closure

Last publications

Bioprosthetic mesh reinforcement during temporary stoma closure decreases the rate of incisional hernia.

A blinded, case-matched study in 94 patients with rectal cancer. Léon Maggiori, MD,a David Moszkowicz, MD,a Magaly Zappa, MD,b Cécile Mongin, MD,a and Yves Panis, MD, PhD,a Clichy, France.

http://dx.doi.org/10.1016/j.surg.2015.07.004